Literature DB >> 19798035

Rejuvenating the immune system in rheumatoid arthritis.

Cornelia M Weyand1, Hiroshi Fujii, Lan Shao, Jörg J Goronzy.   

Abstract

In rheumatoid arthritis (RA), the aging process of the immune system is accelerated. Formerly, this phenomenon was suspected to be a consequence of chronic inflammatory activity. However, newer data strongly suggest that deficiencies in maintaining telomeres and overall DNA stability cause excessive apoptosis of RA T cells, imposing proliferative pressure and premature aging on the system. Already during the early stages of their life cycle, and long before they participate in the inflammatory process, RA T cells are lost owing to increased apoptotic susceptibility. A search for underlying mechanisms has led to the discovery of defective pathways of repairing broken DNA and elongating and protecting telomeric sequences at the chromosomal ends. Two enzymatic machineries devoted to DNA repair and maintenance have been implicated. RA T cells fail to induce sufficient amounts of the telomeric repair enzyme telomerase, leaving telomeric ends uncapped and thus susceptible to damage. Of equal importance, RA T cells produce low levels of the DNA repair enzyme ataxia telangiectasia mutated and the complex of nucleoproteins that sense and fix DNA double-strand breaks. The inability to repair damaged DNA renders naive T cells vulnerable to apoptosis, exhausts T-cell regeneration and reshapes the T cell repertoire. Therapeutic attempts to reset the immune systems of patients with RA and prevent premature immunosenescence should include restoration of DNA repair capability.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19798035     DOI: 10.1038/nrrheum.2009.180

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


  48 in total

Review 1.  Telomere erosion: a new link between HLA DR4 and rheumatoid arthritis?

Authors:  Mike Salmon; Arne N Akbar
Journal:  Trends Immunol       Date:  2004-07       Impact factor: 16.687

Review 2.  The ATM-dependent DNA damage signaling pathway.

Authors:  R Kitagawa; M B Kastan
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2005

Review 3.  Atm and cellular response to DNA damage.

Authors:  Martin F Lavin; Sergei Kozlov; Nuri Gueven; Cheng Peng; Geoff Birrell; Phillip Chen; Shaun Scott
Journal:  Adv Exp Med Biol       Date:  2005       Impact factor: 2.622

Review 4.  Therapeutic T-cell manipulation in rheumatoid arthritis: past, present and future.

Authors:  J D Isaacs
Journal:  Rheumatology (Oxford)       Date:  2008-05-25       Impact factor: 7.580

5.  Perturbation of the T cell repertoire in rheumatoid arthritis.

Authors:  U G Wagner; K Koetz; C M Weyand; J J Goronzy
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

Review 6.  Evidence that cytokines play a role in rheumatoid arthritis.

Authors:  Fionula M Brennan; Iain B McInnes
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

Review 7.  ATM and the Mre11 complex combine to recognize and signal DNA double-strand breaks.

Authors:  M F Lavin
Journal:  Oncogene       Date:  2007-12-10       Impact factor: 9.867

Review 8.  Fibroblasts as novel therapeutic targets in chronic inflammation.

Authors:  S J Flavell; T Z Hou; S Lax; A D Filer; M Salmon; C D Buckley
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

9.  Dysregulated lymphocyte proliferation and differentiation in patients with rheumatoid arthritis.

Authors:  Frederique Ponchel; Ann W Morgan; Sarah J Bingham; Mark Quinn; Maya Buch; Robert J Verburg; Judy Henwood; Susan H Douglas; Aurelie Masurel; Philip Conaghan; Moji Gesinde; Julia Taylor; Alexander F Markham; Paul Emery; Jacob M van Laar; John D Isaacs
Journal:  Blood       Date:  2002-08-08       Impact factor: 22.113

Review 10.  Why do people with rheumatoid arthritis still die prematurely?

Authors:  S E Gabriel
Journal:  Ann Rheum Dis       Date:  2008-12       Impact factor: 19.103

View more
  51 in total

Review 1.  Targets of immune regeneration in rheumatoid arthritis.

Authors:  Philipp J Hohensinner; Jörg J Goronzy; Cornelia M Weyand
Journal:  Mayo Clin Proc       Date:  2014-04       Impact factor: 7.616

Review 2.  The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases.

Authors:  Luca Antonioli; Corrado Blandizzi; Pál Pacher; György Haskó
Journal:  Pharmacol Rev       Date:  2019-07       Impact factor: 25.468

Review 3.  T-cell aging in rheumatoid arthritis.

Authors:  Cornelia M Weyand; Zhen Yang; Jörg J Goronzy
Journal:  Curr Opin Rheumatol       Date:  2014-01       Impact factor: 5.006

Review 4.  Treatment of rheumatoid arthritis: state of the art 2009.

Authors:  Ronald F van Vollenhoven
Journal:  Nat Rev Rheumatol       Date:  2009-10       Impact factor: 20.543

Review 5.  [Immunosenescence. Current status and molecular mechanisms].

Authors:  T Peters
Journal:  Hautarzt       Date:  2011-08       Impact factor: 0.751

Review 6.  Vitamin D in rheumatoid arthritis-towards clinical application.

Authors:  Louisa E Jeffery; Karim Raza; Martin Hewison
Journal:  Nat Rev Rheumatol       Date:  2015-10-13       Impact factor: 20.543

Review 7.  Metabolic syndrome, hormones, and maintenance of T cells during aging.

Authors:  Hui-Chen Hsu; John D Mountz
Journal:  Curr Opin Immunol       Date:  2010-06-28       Impact factor: 7.486

8.  Deficient Activity of the Nuclease MRE11A Induces T Cell Aging and Promotes Arthritogenic Effector Functions in Patients with Rheumatoid Arthritis.

Authors:  Yinyin Li; Yi Shen; Philipp Hohensinner; Jihang Ju; Zhenke Wen; Stuart B Goodman; Hui Zhang; Jörg J Goronzy; Cornelia M Weyand
Journal:  Immunity       Date:  2016-10-11       Impact factor: 31.745

9.  Dampened ERK signaling in hematopoietic progenitor cells in rheumatoid arthritis.

Authors:  Inés Colmegna; Sergey Pryshchep; Hisashi Oishi; Jörg J Goronzy; Cornelia M Weyand
Journal:  Clin Immunol       Date:  2012-01-28       Impact factor: 3.969

Review 10.  Rheumatoid arthritis and cardiovascular disease.

Authors:  Cynthia S Crowson; Katherine P Liao; John M Davis; Daniel H Solomon; Eric L Matteson; Keith L Knutson; Mark A Hlatky; Sherine E Gabriel
Journal:  Am Heart J       Date:  2013-08-29       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.